US 12,161,841 B2
Insulin delivery methods, systems and devices
Bryan Mazlish, Palo Alto, CA (US); and Lane Desborough, Thousand Oaks, CA (US)
Filed by Insulet Corporation, Acton, MA (US)
Filed on Jun. 7, 2021, as Appl. No. 17/303,733.
Application 17/303,733 is a continuation of application No. 15/870,703, filed on Jan. 12, 2018, granted, now 11,027,063.
Claims priority of provisional application 62/563,804, filed on Sep. 27, 2017.
Prior Publication US 2021/0290845 A1, Sep. 23, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61M 5/172 (2006.01); A61B 5/145 (2006.01); A61M 5/142 (2006.01); G16H 20/17 (2018.01); A61B 5/00 (2006.01); A61K 38/28 (2006.01); A61M 5/00 (2006.01); A61M 5/315 (2006.01)
CPC A61M 5/1723 (2013.01) [A61B 5/14532 (2013.01); A61M 5/14248 (2013.01); G16H 20/17 (2018.01); A61B 5/4839 (2013.01); A61K 38/28 (2013.01); A61M 5/003 (2013.01); A61M 5/31568 (2013.01); A61M 2205/35 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2230/201 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A medication delivery monitoring system comprising:
a medication delivery device configured to deliver medication to a user; and
a controller comprising:
at least one processor; and
at least one non-transitory computer-readable storage medium storing instructions thereon that, when executed by the at least one processor, cause the controller to:
responsive to receiving data associated with a previous medication delivery action, determine a correction dose; and
compare the correction dose with a threshold medication delivery amount; and
an alert indicator for indicating an alert responsive to the comparison of the correction dose with the threshold delivery amount.